Rapt Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 3.24%156.850.0%$2874.77m
BNGOBioNano Genomics, Inc. -4.42%11.670.0%$2406.99m
GILDGilead Sciences, Inc. -1.95%65.401.0%$642.57m
AMGNAmgen, Inc. -1.73%254.141.3%$574.57m
REGNRegeneron Pharmaceuticals, Inc. -4.01%522.312.7%$478.04m
ALXNAlexion Pharmaceuticals, Inc. -2.05%158.442.0%$465.61m
ILMNIllumina, Inc. -0.42%418.773.5%$441.93m
CRSPCRISPR Therapeutics AG -2.09%165.990.6%$436.26m
NVAXNovavax, Inc. -0.42%126.6392.9%$405.41m
VRTXVertex Pharmaceuticals, Inc. -4.70%226.481.9%$361.72m
SRPTSarepta Therapeutics, Inc. -1.94%90.8513.8%$336.74m
BIIBBiogen, Inc. -2.91%263.771.7%$314.20m
BNTXBioNTech SE 0.48%106.800.0%$309.42m
EXASEXACT Sciences Corp. -3.06%136.7219.6%$243.95m
SRNESorrento Therapeutics, Inc. 17.37%12.231.4%$210.47m

Company Profile

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.